The abstract is read at the publisher; the summary is JClub's.
The European Respiratory Journal clinical practice guideline for long COVID prevention and treatment provides timely recommendations, but evidence remains limited, heterogeneous, and often low-certainty.
- Why it matters: The field needs better guidance that can be interpreted consistently and used to identify who is most likely to benefit, despite uneven evidence quality.
- What they did: The guideline covers prevention and treatment options, including vaccination and acute-phase antiviral therapy, plus symptom-directed interventions like cognitive behavioural therapy, multi-species probiotics, and personalised rehabilitation after excluding post-exertional malaise.
- The result: Future updates and trials should incorporate reinfection history, reproducible biological characteristics, and equity-relevant risks to improve interpretation and patient targeting.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.